$393.61
▲ +0.0% Today
as of Jul 22, 09:18 ET
Last 30 days
Recent Press Releases & News
lean bull
▲ 5
● 20
▼ 0
The Hidden Engine Behind Elevance Health Stock's Next Climb
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now?
Elevance Health CEO Snaps Up Stock After Post-Earnings Slide
Overview
52-week range
$274
$417
84% of range
Avg surprise (last 2)
-1.7%
Avg reaction (last 2)
-5.0%
50% positive
Latest IV / EM
33%
EM ±7.7% · $390 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $8.00 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $5.32 | — | — | — | — | financials |
| Thu Jul 17, 2025 | Jun/2025 | $8.84 | $9.16 | -3.5% | — | -12.2% | earnings |
| Tue Apr 22, 2025 | Mar/2025 | $11.97 | $11.97 | 0.0% | — | +2.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $4.36 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $9.85 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $9.59 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $5.45 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $7.79 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $50.18B | — | $50.71B | $49.78B | $48.89B | — | $45.11B | $43.89B |
| Cost of revenue | $5.46B | — | $5.38B | $5.29B | $4.98B | — | $5.09B | $4.82B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $2.09B | — | $1.29B | $2.42B | $3.17B | — | $1.41B | $2.77B |
| Net income | $1.76B | — | $1.19B | $1.74B | $2.18B | — | $1.02B | $2.30B |
| EPS (diluted) | $8.00 | — | $5.32 | $7.72 | $9.61 | — | $4.36 | $9.85 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9.66B | $9.49B | $8.71B | $8.56B | $7.50B | $8.29B | $7.87B | $6.50B |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $67.03B | $63.00B | $63.78B | $63.32B | $61.12B | $58.94B | $62.85B | $62.27B |
| Total assets | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B |
| Long-term debt | $30.77B | $30.80B | $31.17B | $28.18B | $28.11B | $29.22B | $24.69B | $24.56B |
| Total liabilities | $81.78B | $77.47B | $78.67B | $78.09B | $77.10B | $75.46B | $72.65B | $70.69B |
| Total equity | $43.90B | $43.88B | $43.95B | $43.72B | $42.50B | $41.31B | $43.77B | $42.19B |